Clinical significance and changes in antimicrobial resistance in ESBL producers isolated over the 2014-2016 in a regional teaching hospital | CMAC

Clinical significance and changes in antimicrobial resistance in ESBL producers isolated over the 2014-2016 in a regional teaching hospital

Clinical Microbiology and Antimicrobial Chemotherapy. 2017; 19(4):341-344

​ Ortenberg E.A., Shpilkina L.V., Khokhlyavina R.M., Kirushok G.I., Khristenko Ya.V.
E. coli K. pneumoniae ESBL antimicrobial resistance
Section
Personal Experience
Type
Journal article
Publication
Clinical Microbiology and Antimicrobial Chemotherapy. 2017; 19(4):341-344

Abstract

The role of Escherichia coli and Klebsiella pneumoniae in the etiology of respiratory tract, bloodstream, urinary tract and soft tissue infections in the Tyumen Regional Clinical Hospital has been evaluated for three years time period (2014-2016). Dependence of antimicrobial resistance of the above mentioned pathogens was estimated in accordance with the ESBL production status. The results of the study resembled the country-level data with some local features.

Eduard A. Ortenberg

Tyumen State Medical University, Tyumen, Russia

Shpilkina L.V.

Regional Clinical Hospital #1, Tyumen, Russia

Khokhlyavina R.M.

Regional Clinical Hospital #1, Tyumen, Russia

Kirushok G.I.

Regional Clinical Hospital #1, Tyumen, Russia

Khristenko Ya.V.

Tyumen State Medical University, Tyumen, Russia

  • 1. Pitout J.D., Laupland K.B. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008;8(3):159-166.
  • 2. Nijssen S., Florijn A., Bonten M.J. Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates. Int J Antimicrob Agents. 2004;24:585-591.
  • 3. Bochicchio G.V., Baquero F., Hsueh P.R., et al. In vitro susceptibilities of Escherichia coli isolated from patients with intra-abdominal infections worldwide in 2002-2004: results from SMART (Study for Monitoring Antimicrobial Resistance Trends). Surg Infect (Larchmt). 2006;7(6):537-545.
  • 4. Edelstein M.V., Stratchounski L.S., and the ROSNET study group. Trends in the Prevalence and Susceptibility of ESBL-producing Enterobacteriaceae to Various Antimicrobial Agents in Russian ICUs. Klinicheskaja Mikrobiologija i Antimikrobnaja Himioterapija. 2005;7(4):323-336. Russian.
  • 5. Ryabkova E.L., Ivanchik N.V., Sukhorukova M.V., et al. Antimicrobial Resistance of Nosocomial Strains of Escherichia coli in Russian Hospitals. Klinicheskaja Mikrobiologija i Antimikrobnaja Himioterapija. 2009;11(2):161-169. Russian.
  • 6. Livermore D.M. Current Epidemiology and Growing Resistance of GramNegative Pathogens. Korean J Intern Med. 2012;27(2):128-142.
  • 7. Wilson J., Elgohari S., Livermore D.M., et al. Trends among pathogens reported as causing bacteraemia in England, 2004-200
  • 8. Clin Microbiol Infect. 2011;17:451-458. 8. Munoz-Price L.S., Poirel L., Bonomo R.A., et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13:785-796.
  • 9. Höjgård S. Antibiotic resistance – why is the problem so difficult to solve? Infect Ecol Epidemiol. 2012;2:10.3402/iee.v2i0.18165.
  • 10. Palacios-Baena Z.R., Gutiérrez-Gutiérrez B., De Cueto M., et al. Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-β-lactamase-producing Enterobacteriaceae. J Antimicrob Chemother. 2017;72(3):906-913.
Views
0 Abstract
0 PDF
0 Crossref citations
Shared